Skip to content

Advertising disclosure: We earn commissions from some of the products we link to. It never changes our scores or what we publish. Read the full disclosure

Tom’s Weight LossRankings
CompoundedNot tested · not scored

Remedy Meds

Remedy Meds

Remedy Meds offers compounded semaglutide and tirzepatide at scale, and publishes outcome claims drawn from self-reported data across roughly 300,000 members. It labels that data as self-reported, which is the right disclosure to make.

Sources captured · researched by Tom

Medications offered

As listed on the provider’s own site. Whether a product is FDA-approved or compounded is the single most important distinction here — we explain why.

  • Compounded semaglutideCompounded · not FDA-approved
  • Compounded tirzepatideCompounded · not FDA-approved

What they publish

Remedy Meds publishes 0 of 12 standard terms. Fields marked “not publicly disclosed” were not stated on the pages we captured, and we have not filled those gaps with assumptions. Compare disclosure across providers

Membership / programme fee
Specific pricing was not published on the page we captured
Medication cost
Not publicly disclosed on the pages we captured.
Introductory offer
Not publicly disclosed on the pages we captured.
Insurance
Not publicly disclosed on the pages we captured.
HSA / FSA
Not publicly disclosed on the pages we captured.
Consultation process
Not publicly disclosed on the pages we captured.
Eligibility
Not publicly disclosed on the pages we captured.
Lab work
Not publicly disclosed on the pages we captured.
Pharmacy fulfilment
Not publicly disclosed on the pages we captured.
Shipping
Not publicly disclosed on the pages we captured.
Support services
Not publicly disclosed on the pages we captured.
Cancellation
Not publicly disclosed on the pages we captured.
Refunds
Not publicly disclosed on the pages we captured.

What stands out

  • Publishes outcome figures based on self-reported data from around 300,000 members, and labels them as self-reported rather than presenting them as trial results.
  • Self-reported outcome data from a company's own customers is much weaker evidence than a randomised trial, and is subject to survivorship bias — the people who stopped are less likely to report.
  • Compounded only.

Questions to ask before you pay

These are things we could not settle from published pages, or that we think are easy to misread. Get answers in writing.

  • Treat self-reported member outcomes as marketing rather than evidence.
  • Establish the monthly cost, which was not published on the page we captured.
  • Ask which pharmacy compounds the product and whether it is 503A or 503B.

Limitations

  • Compounded only.
  • No pricing published.

Sources

Captured . Pages change — check the current version before relying on anything here.

Worth comparing against

Brand-nameCompoundedInsurance support

Mochi Health

Mochi Health

Flat membership with medication billed separately, and clear on-page compounding disclosure

Membership
from $79/mo
Medication
Billed separately
Publishes7/12 terms
Compounded

Orderly Meds

Orderly Meds

The lowest published entry price here — and a four-fold step up afterwards

Membership
from $74/mo
Medication
Included
Publishes1/12 terms
Insurance support

ElixMD

ElixMD

Cash-pay only, no appointments, two-day delivery advertised

Membership
Not published
Medication
Not published
Publishes2/12 terms